Printer Friendly

MYCOGEN HIRES PRESIDENT TO HEAD NEW SUBSIDIARY FOCUSING ON ANIMAL AND HUMAN HEALTH MARKETS

           MYCOGEN HIRES PRESIDENT TO HEAD NEW SUBSIDIARY
             FOCUSING ON ANIMAL AND HUMAN HEALTH MARKETS
    SAN DIEGO, June 18 /PRNewswire/ -- Mycogen Corp. (NASDAQ: MYCO), a leader in the development of environmentally compatible biological pest control for agricultural crops, has appointed Charles J. Dumbrell to head up a newly formed subsidiary that will apply Mycogen's core technology to products to control pests that threaten human and animal health.
    The new company, Parasitix Corp., will have access to Mycogen's extensive patent estate, which includes rights to a broad range of pesticidal toxins derived from the Bacillus thuringiensis (Bt) bacterium, as well as pesticidal agents based on fatty acids.
    Dumbrell, who has more than 25 years of extensive experience in manufacturing, marketing, sales and management of global businesses in the chemical, pharmaceutical and agricultural industries, has been appointed president of Parasitix.  Most recently, he was with American Cyanamid Co.'s chemical group with responsibility for new projects, business restructuring and divestiture management.
    "We are pleased to welcome Chuck Dumbrell aboard to explore the vast collaborative opportunities available to us in the areas of human and animal health," said Jerry Caulder, Mycogen's chairman, president and chief executive officer.  "His extensive background in all facets of running an international organization will be extremely useful in getting this new subsidiary up and operating."
    "Our research has confirmed that Bts are effective against certain pests affecting animals and human, as well as many household pests.  Parasitix's primary focus will be to target this tremendous opportunity," Caulder noted.
    The cover story of the March issue of BioTechnology, reported that Mycogen had isolated Bt toxins active against such non-insect organisms as protozoan pathogens, mites and liver flukes, and had found new activity against adult houseflies. Mycogen holds 22 of the 39 U.S. patents issued for new Bt strains over the past four years.
    Mycogen provides crop protection products and services. The company develops, manufactures and markets environmentally compatible products based on naturally occurring agents to control insects, parasites, weeds and other pests.  Mycogen develops its products through the application of genetic engineering techniques and innovative formulations.
    -0-                    6/18/92
    /CONTACT:  Charles J. Dumbrell, president of Parasitix, or Marie C.Burke (investors) of Mycogen, 619-453-8030/
    (MYCO) CO:  Mycogen Corp.; Parasitix Corp. ST:  California IN:  CHM MTC SU:  PER JL -- SD003 -- 1354 06/18/92 08:33 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jun 18, 1992
Words:388
Previous Article:'ELECTRONIC INFORMATION NEWS' SYSTEM DEBUTS IN FLORIDA UTF AND BRITE VOICE FORM STRATEGIC PARTNERSHIP
Next Article:MRI MEDICAL DIAGNOSTICS ANNOUNCES EXECUTION OF FINAL PURCHASE AGREEMENT AND THE CLOSING OF A MAJOR IMAGING CENTER
Topics:


Related Articles
SECRETARY OF AGRICULTURE APPOINTS MYCOGEN CORP. CHAIRMAN TO ALTERNATIVE AGRICULTURE RESEARCH AND COMMERCIALIZATION BOARD
MYCOGEN'S PARASITIX SUBSIDIARY BUYS
MYCOGEN, SCHERING-PLOUGH UNITS SIGN AGREEMENT TO MARKET BIOCONTROL PRODUCTS FOR POULTRY
MYCOGEN, SCHERING-PLOUGH UNITS SIGN AGREEMENT TO MARKET BIOCONTROL PRODUCTS FOR POULTRY
MYCOGEN ANNOUNCES CFO'S DEPARTURE
MYCOGEN RECEIVES NOTICE OF ALLOWANCE FOR EUROPEAN PATENT COVERING Bt GENE TECHNOLOGY FOR INSECT-RESISTANT PLANTS
Global Agro, Inc. Elects New Board Members.
MARKETING PEOPLE.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters